Literature DB >> 29173188

Innate Immune Surveillance in the Central Nervous System Following Legionella pneumophila Infection.

Pasqualina Lagana1, Luca Soraci1, Maria Elsa Gambuzza2, Giuseppe Mancuso3, Santi Antonino Delia1.   

Abstract

BACKGROUND &
OBJECTIVE: The innate immune response is a common occurrence in many neuroinflammatory diseases. Central Nervous System (CNS) resident immune cells are able to detect and react to infections and sterile trauma. Peripheral immune cell migration into CNS is regulated by the blood-brain barrier, although peripheral immune cells can invade CNS through meninges, choroid plexus, perivascular spaces, and cerebrospinal fluid. Consequently, in the brain, immune reactions can be mediated by both resident and peripheral immune cells. Both in the periphery and within the CNS, innate immune response is regulated by a wide array of pattern recognition receptors, including Tolllike, scavenger, Retinoic Acid-inducible Gene-1 like, and nucleotide-binding oligomerization domainslike responsible for inflammasome formation. Inflammasome pathway activation induces pyroptosis, a highly inflammatory cell death pattern that occurs to remove intracellular pathogens. Legionella pneumophila is an intracellular microorganism responsible for Legionnaires' disease, a lung infection always associated to neurological dysfunctions. Recent studies have been shown that Toll-like receptors, nucleotide-binding oligomerization domains-like receptors, and RIG-1 like, are activated by L. pneumophila. This flagellated bacterium is able to replicate in phagocytic cells, including macrophages and microglia, responding by activating inflammasome pathways that may be the cause of CNS dysfunction detected in several infected patients.
CONCLUSION: The aim of this review is to bring together the latest findings concerning L. pneumophila infection and innate immune host cell responses. A deeper knowledge of these processes could allow the use of immunomodulatory compounds able to counteract CNS involvement following L. pneumophila infection. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Central nervous system; Legionella pneumophila; inflammation; innate immunity; legionnaire’s disease; patternzzm321990recognition receptors.

Mesh:

Substances:

Year:  2017        PMID: 29173188     DOI: 10.2174/1871527316666171123210420

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


  5 in total

1.  Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease.

Authors:  Xianglian Meng; Jin Li; Qiushi Zhang; Feng Chen; Chenyuan Bian; Xiaohui Yao; Jingwen Yan; Zhe Xu; Shannon L Risacher; Andrew J Saykin; Hong Liang; Li Shen
Journal:  BMC Genomics       Date:  2020-12-29       Impact factor: 3.969

2.  Cerebellar ataxia a unique initial presentation of Legionnaires' disease.

Authors:  Zaid Kaloti; Kendall Bell; Mowyad Khalid; Diane Levine
Journal:  BMJ Case Rep       Date:  2020-03-10

3.  Environmental Surveillance of Legionellosis within an Italian University Hospital-Results of 15 Years of Analysis.

Authors:  Pasqualina Laganà; Alessio Facciolà; Roberta Palermo; Santi Delia
Journal:  Int J Environ Res Public Health       Date:  2019-03-28       Impact factor: 3.390

4.  ChIP-seq Profiling Identifies Histone Deacetylase 2 Targeting Genes Involved in Immune and Inflammatory Regulation Induced by Calcitonin Gene-Related Peptide in Microglial Cells.

Authors:  Xingjing Guo; Dan Chen; Shuhong An; Zhaojin Wang
Journal:  J Immunol Res       Date:  2020-08-04       Impact factor: 4.818

Review 5.  Overview of the Clinical and Molecular Features of Legionella Pneumophila: Focus on Novel Surveillance and Diagnostic Strategies.

Authors:  Giuseppe Gattuso; Roberta Rizzo; Alessandro Lavoro; Vincenzoleo Spoto; Giuseppe Porciello; Concetta Montagnese; Diana Cinà; Alessia Cosentino; Cinzia Lombardo; Maria Lina Mezzatesta; Mario Salmeri
Journal:  Antibiotics (Basel)       Date:  2022-03-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.